logo
Denison Mines Unveils New High-Grade Uranium Discovery at Gryphon

Denison Mines Unveils New High-Grade Uranium Discovery at Gryphon

Globe and Mail3 days ago
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Denison Mines ( (TSE:DML)) has shared an announcement.
Denison Mines Corp. has announced the discovery of additional high-grade mineralization at its Gryphon uranium deposit, located near its flagship Phoenix project in northern Saskatchewan. This discovery, made during a successful delineation drill program, is expected to enhance the confidence in Gryphon's mineral resources and potentially expand the deposit's estimated mineral resources. The results support further project development and de-risking efforts, highlighting Gryphon's potential as a competitive, low-cost uranium mining operation.
The most recent analyst rating on (TSE:DML) stock is a Buy with a C$2.60 price target. To see the full list of analyst forecasts on Denison Mines stock, see the TSE:DML Stock Forecast page.
Spark's Take on TSE:DML Stock
According to Spark, TipRanks' AI Analyst, TSE:DML is a Neutral.
Denison Mines' overall stock score reflects significant challenges in financial performance due to ongoing losses and cash flow inefficiencies. However, the company's strong equity position and proactive corporate events, such as advancing key projects and strengthening governance, provide a positive outlook for future strategic growth. Technical indicators suggest a cautious approach due to a lack of upward momentum. Valuation metrics indicate the stock is not currently attractive for traditional investors, as reflected by the negative P/E ratio and absence of a dividend yield.
To see Spark's full report on TSE:DML stock, click here.
More about Denison Mines
Denison Mines Corp. operates in the uranium mining industry, focusing on the exploration and development of uranium deposits. The company is primarily engaged in projects in northern Saskatchewan, Canada, with its flagship project being the Phoenix In-Situ Recovery uranium mine. Denison is known for its high-grade uranium deposits, including the Gryphon deposit, which is a significant part of its portfolio.
Average Trading Volume: 2,660,758
Technical Sentiment Signal: Strong Buy
Current Market Cap: C$2.27B
See more insights into DML stock on TipRanks' Stock Analysis page.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

iHeartMedia, Inc. to Report Quarterly Financial Results on August 11, 2025
iHeartMedia, Inc. to Report Quarterly Financial Results on August 11, 2025

Globe and Mail

timea few seconds ago

  • Globe and Mail

iHeartMedia, Inc. to Report Quarterly Financial Results on August 11, 2025

iHeartMedia, Inc. (NASDAQ: IHRT) announced today that on Monday August 11th, 2025, it will issue financial results for the quarter ending June 30, 2025. The company will conduct a conference call at 4:30 p.m. (ET), following the release of its earnings announcement, to discuss its financial results and business outlook. A live audio webcast of the call will be available on the Investors homepage of iHeartMedia's website ( beginning at 4:30 p.m. (ET) on August 11th. The conference call can also be accessed by dialing (888) 596-4144 (domestic) or +1 646 968-2525 (international) using PIN number 8885116 followed by # key. Please call at least five minutes in advance to ensure that you are connected prior to the call. An audio replay of the call will be available beginning at 7:30 p.m. (ET) on August 11th in the Events & Presentations section of iHeartMedia's Investors home page, and at (800) 770-2030 (domestic) or +1 609 800-9909 (international) using PIN number 8885116 followed by # key. The audio replay will be available for a period of thirty days. The earnings release and any other information related to the call will be accessible on the Investors home page of iHeartMedia's website. About iHeartMedia, Inc. iHeartMedia, Inc. [Nasdaq: IHRT] is the leading audio media company in America, reaching over 250 million people each month. It is number one in both broadcast and digital streaming radio as well as podcasting and audio ad tech, and includes three business segments: The iHeartMedia Multiplatform Group; the iHeartMedia Digital Audio Group; and the Audio and Media Services Group. Visit for more company information.

Canada-UK Collaboration Developing AI-powered Bioreactors to Revolutionise Biopharmaceutical Manufacturing
Canada-UK Collaboration Developing AI-powered Bioreactors to Revolutionise Biopharmaceutical Manufacturing

National Post

time27 minutes ago

  • National Post

Canada-UK Collaboration Developing AI-powered Bioreactors to Revolutionise Biopharmaceutical Manufacturing

Article content KITCHENER, Ontario & United Kingdom — An international initiative will transform biologics and drug manufacturing through AI-driven multiplatform integration. The AI-optimised BALANCE (Bioreactor Automation for Learning and Adaptive Networked Control of Experiments) platform will leverage Nicoya's real-time sensing and control systems, integrated with automation from Labman Automation, bioreactor technologies from CPI, and AI development by Basetwo to make bioprocessing smarter, more efficient, and faster. Article content The 20-month collaboration, led by Labman, is supported by a $2 million grant from Innovate UK and the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) through a Canada-UK Collaborative R&D initiative. The goal of the project is to deliver an AI-optimised demonstrator platform integrating bioreactor technologies with real-time sensing and control systems. It will leverage the joint expertise of the partners, bringing together the latest in AI, automation, and real-time process control to streamline upstream bioprocessing, ensuring higher yields, lower costs, and improved scalability for next-generation therapeutics. This aims to enhance the precision and efficiency of biologic drug production, offering a smarter, faster path to market. Article content Bioprocessing is an often-inefficient part of manufacturing that can slow down biopharma development. Optimizing bioprocessing requires making bioreactor operation more dynamic, relying on real-time data from biosensors. At the core of the BALANCE initiative is a closed-loop AI control system powered by Basetwo's digital twin platform. The machine learning models will interpret real-time data from the bioreactor and biosensors, enabling adaptive control of experimental conditions for real-time optimization of bioreactor performance. Labman will build an automated modular sampling platform that will automate molecular analysis, integrating seamlessly with Nicoya's Alto SPR biosensor for instant yield data and adaptive process control. Article content Basetwo's digital twin technology further enhances efficiency by predicting quality outcomes and reducing reliance on costly lab testing. CPI will validate and benchmark the system, ensuring practical scalability and commercial viability for biologics manufacturing. Article content This project marks a major step forward in digital bioprocessing, paving the way for increased efficiency, reduced variability, and faster time-to-market for breakthrough biologics. As an AI-driven testbed for next-generation model-based process control, the platform holds transformative potential for pharma and biotech industries striving for scalable, cost-effective production solutions. Article content 'Until now, sensing technology has been too slow and complex to enable truly reactive bioprocessing,' said Ryan Denomme, co-founder and CEO of Nicoya. 'Label-free biosensing is critical to unlocking the potential for automation and AI to drive efficiency in biomanufacturing, overcoming the complexity inherent in systems dealing with the diversity of living organisms. We look forward to working with our BALANCE partners to solve a bottleneck that can accelerate drug development.' Article content 'This is the next step for biologics and drug manufacturing, integrating Industry 4.0 approaches for bioprocessing,' said Thomas Smith, Head of Bioprocess Automation at Labman. 'By combining advanced sensing, AI and automation, we aim to accelerate process development, improve consistency, and create smarter, more efficient biomanufacturing workflows.' Article content Brendan Fish, Director of Biologics at CPI: 'Pharmaceutical companies know they must embrace digitalisation to stay competitive, but integrating digital technologies has been challenging in an industry that can be slow to evolve. Through collaboration, BALANCE is bridging this gap by validating and scaling AI-driven bioprocessing solutions to accelerate adoption and translate advancements into real-world impact for biologics manufacturing.' Article content 'AI-enabled digital twins is the next frontier in intelligent manufacturing,' said Thouheed Abdul Gaffoor, CEO at Basetwo. 'By combining our hybrid modelling approach with advanced sensing and automation, this collaboration moves us closer to autonomous biomanufacturing, cutting time, cost, and variability in producing life-saving therapeutics.' Article content About Nicoya Article content Nicoya is a Canadian life sciences tools company that specializes in biosensor technology. Its Alto Digital SPR platform delivers label-free, real-time biomolecular analysis, streamlining bioprocess development and monitoring. Article content About Labman Article content Labman Automation is a UK-based engineering company that designs and builds bespoke robotic systems and laboratory automation solutions. With a strong focus on flexibility, creativity, and engineering excellence, Labman helps customers across industries streamline operations and push the boundaries of what's possible in automated research and manufacturing. Article content About CPI Article content CPI catalyses the adoption of advanced technologies and manufacturing solutions to benefit people, places, and our planet. As part of the High Value Manufacturing Catapult, CPI helps accelerate innovation in HealthTech, pharma, AgriFoodTech, and beyond through world-class infrastructure and expertise. Article content About Basetwo Article content Basetwo is an AI platform helping process engineers in pharmaceutical and chemical manufacturing optimize operations using hybrid modelling. The platform provides engineers with recommendations on the next best action they can implement to maximize product quality, production yield, and process efficiency. Article content Article content Article content Article content Article content

NTT DATA Appoints Beth Howen President of State, Local and Education
NTT DATA Appoints Beth Howen President of State, Local and Education

National Post

time27 minutes ago

  • National Post

NTT DATA Appoints Beth Howen President of State, Local and Education

Article content PLANO, Texas — NTT DATA, a global leader in digital business and technology services, is pleased to announce the appointment of Beth Howen as the new President of its State and Local Government and Education (SLED) business in North America. Article content Beth brings a wealth of experience as a dynamic and results-driven digital and operations executive. Her career spans leadership roles at Capgemini, Telus International, Atos and the City of Indianapolis, where she led transformative initiatives across strategic planning, process optimization and technology integration. Her efforts have consistently delivered enterprise-wide improvements and positioned organizations for long-term growth. Article content Article content 'I'm excited to join NTT DATA and lead our SLED business into the next era of growth through innovation,' said Howen. 'State and local government agencies and education institutions are embracing acceleration of their digital transformation journeys, and I look forward to helping our clients modernize operations with secure digital environments that meet the needs of the citizens and communities they serve.' Article content Beth has successfully led large-scale transformation projects and secured major deals with numerous state and local government agencies. Her deep expertise in public sector innovation and her commitment to strategic partnerships will be instrumental as she leads NTT DATA's SLED team with a renewed focus on education and multi-state initiatives. Article content 'We're delighted to welcome Beth to the NTT DATA leadership team,' said Tanvir Khan, Chief Operating Officer, NTT DATA North America. 'Her proven expertise and forward-thinking approach will be key as we help SLED clients modernize and deliver secure, citizen-focused digital services nationwide.' Article content NTT DATA is a $30+ billion global innovator of digital business and technology services. We serve 75% of the Fortune Global 100 and are committed to helping clients innovate, optimize and transform for long-term success. As a Global Top Employer, we have experts in more than 50 countries and a robust partner ecosystem of established and startup companies. Our services include business and technology consulting, data and artificial intelligence, industry solutions, as well as the development, implementation and management of applications, infrastructure and connectivity. We are also one of the leading providers of digital and AI infrastructure in the world. NTT DATA is part of NTT Group, which invests over $3.6 billion each year in R&D to help organizations and society move confidently and sustainably into the digital future. Article content Article content

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store